BRAF and colorectal carcinoma: Another classification is based on altered gene expression, which has been compiled by the CRC Subtyping Consortium and is called the consensus molecular subtypes (CMS) of CRC [8]: CMS1 (approximately 14% of all CRCs) is associated with MSI, BRAF mutation, promoter hypermethylation, and immune infiltration.